A synthetic fragment corresponding to the actin-binding region of Thymosin β4. Marketed for systemic repair and often stacked with BPC-157. Most published work studies the full Tβ4 protein rather than this fragment.
Research compound — not approved for human use. Compounds in this category have not been approved for human use; availability is typically restricted to laboratory research.
Ranges compiled from published protocols, not a clinical guideline. Convert a dose into syringe units with the dosage calculator.
This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.
Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.